MIM
CELL

MetLife Investment Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

MetLife Investment Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,322
Closed -$51.8K – 2829
2022
Q4 		$51.8K Sell
19,322
-8,507
-31% -$22.4K ﹤0.01% 2755
2022
Q3 		$79.6K Hold
27,829
– – ﹤0.01% 2727
2022
Q2 		$138K Buy
27,829
+6,270
+29% +$32.8K ﹤0.01% 2542
2022
Q1 		$153K Buy
21,559
+4,199
+24% +$34.7K ﹤0.01% 2504
2021
Q4 		$316K Hold
17,360
– – ﹤0.01% 1782
2021
Q3 		$340K Hold
17,360
– – ﹤0.01% 1756
2021
Q2 		$778K Buy
17,360
+9,616
+124% +$446K 0.01% 1316
2021
Q1 		$389K Buy
+7,744
New +$528K ﹤0.01% 1666

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

MetLife Investment Management's CELL Position: Q1 2023 in Review

MetLife Investment Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 19,322 shares — an estimated $51.8K sold.

MetLife Investment Management first reported a position in CELL in Q1 2021 and held it in 8 quarters. The position peaked at $778K in Q2 2021. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • MetLife Investment Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • MetLife Investment Management sold 19,322 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $51.8K.
  • MetLife Investment Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • MetLife Investment Management's PhenomeX Inc. Common Stock position peaked at $778K in Q2 2021.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.